{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:25:47Z","timestamp":1769851547317,"version":"3.49.0"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Introduction\/Background<\/jats:title>\n Due to limits in available staff and space during the COVID-19 pandemic, home monitoring programmes were introduced, reducing strain on resources, and preventing readmissions. Several hospitals included prophylaxis for venous thrombotic events (VTE), as COVID-19 appeared to be thrombogenic. Other hospitals did not, expecting patients to be more mobile while at home. Our aim was to determine whether the administration of nadroparin has led to a difference in VTE occurrence between two groups of previously included patients.<\/jats:p>\n <\/jats:sec>\n \n Materials and methods<\/jats:title>\n Retrospective cohort study of two cohorts included in home monitoring with the same protocol, except for nadroparin prophylaxis.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n 663 patients were analysed in equal groups from two hospitals. No significant difference was found in occurrence of VTE after discharge, readmissions in general or readmissions due to VTE in otherwise comparable groups.<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n As opposed to trials determining thrombotic prophylaxis was of benefit after discharge due to COVID-19, we found no difference between our groups. Our study was retrospective and comprised data compiled over almost two years, which provides a relatively large sample size and overview through different treatment regimes.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n For the future, thrombotic prophylaxis for COVID-19 home monitoring might not be indicated and reconsidered for different home monitoring programmes.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0340889","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:32:35Z","timestamp":1769797955000},"page":"e0340889","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extended thrombotic prophylaxis in COVID-19 early discharge: A retrospective cohort study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8845-2515","authenticated-orcid":true,"given":"Sebastiaan T.","family":"van\u2019t Hoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gea","family":"Helfrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanne","family":"Boerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans A.","family":"Hardeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"11","key":"pone.0340889.ref001","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/jamia\/ocaa168","article-title":"Home telemonitoring makes early hospital discharge of COVID-19 patients possible","volume":"27","author":"LA Grutters","year":"2020","journal-title":"J Am Med Inform Assoc"},{"key":"pone.0340889.ref002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.congress-2021.PA914","article-title":"The impact of Covid-19 on hospital length of stay and resources: an experience from a tertiary respiratory centre in the UK","author":"R Wang","year":"2021","journal-title":"Epidemiology"},{"issue":"5","key":"pone.0340889.ref003","doi-asserted-by":"crossref","first-page":"2101871","DOI":"10.1183\/13993003.01871-2021","article-title":"Home-monitoring reduces hospital stay for COVID-19 patients","volume":"58","author":"LA Grutters","year":"2021","journal-title":"Eur Respir J"},{"key":"pone.0340889.ref004","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijid.2020.11.204","article-title":"Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany","volume":"103","author":"M Ludwig","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"10319","key":"pone.0340889.ref005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(21)02392-8","article-title":"Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial","volume":"399","author":"E Ramacciotti","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"pone.0340889.ref006","doi-asserted-by":"crossref","first-page":"2100636","DOI":"10.1183\/13993003.00636-2021","article-title":"Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project","volume":"58","author":"E Dirikgil","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"pone.0340889.ref007","article-title":"COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral Infection","volume":"6","author":"S Sharma","year":"2022","journal-title":"TH Open"},{"issue":"5","key":"pone.0340889.ref008","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"N Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"pone.0340889.ref009","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"FA Klok","year":"2020","journal-title":"Thrombosis Research"},{"issue":"6","key":"pone.0340889.ref010","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/jth.14844","article-title":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19","volume":"18","author":"M Dolhnikoff","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1","key":"pone.0340889.ref011","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19","volume":"76","author":"I Paranjpe","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"pone.0340889.ref012","volume-title":"Coronavirus disease 2019 (COVID-19) treatment guidelines","year":"2021"},{"issue":"11","key":"pone.0340889.ref013","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score","volume":"8","author":"S Barbar","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"8","key":"pone.0340889.ref014","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/jth.14929","article-title":"Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"AC Spyropoulos","year":"2020","journal-title":"J Thromb Haemost"},{"key":"pone.0340889.ref015","unstructured":"Niet WMO en Privacy. https:\/\/www.metc-ldd.nl\/algemene-informatie\/niet-wmo-en-privacy"},{"issue":"6","key":"pone.0340889.ref016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.tem.2023.03.002","article-title":"Long COVID: pathophysiological factors and abnormalities of coagulation","volume":"34","author":"S Turner","year":"2023","journal-title":"Trends Endocrinol Metab"},{"issue":"14","key":"pone.0340889.ref017","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa1014475","article-title":"Dalteparin versus unfractionated heparin in critically ill patients","volume":"364","author":"PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"pone.0340889.ref018","doi-asserted-by":"crossref","first-page":"10760296221148477","DOI":"10.1177\/10760296221148477","article-title":"Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis","volume":"29","author":"F Mehrabi","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"issue":"11","key":"pone.0340889.ref019","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1182\/blood.2020008086","article-title":"Postdischarge venous thromboembolism following hospital admission with COVID-19","volume":"136","author":"LN Roberts","year":"2020","journal-title":"Blood"},{"issue":"3","key":"pone.0340889.ref020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s11739-022-03170-y","article-title":"POST-discharge thromboprophylaxis in patients with COVID-19: a single-center experience","volume":"18","author":"C Simion","year":"2023","journal-title":"Intern Emerg Med"},{"issue":"9","key":"pone.0340889.ref021","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/10600280211064306","article-title":"Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge","volume":"56","author":"LA Courtney","year":"2022","journal-title":"Ann Pharmacother"},{"issue":"6","key":"pone.0340889.ref022","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.tem.2023.03.002","article-title":"Long COVID: pathophysiological factors and abnormalities of coagulation","volume":"34","author":"S Turner","year":"2023","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"pone.0340889.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002797","article-title":"Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis","volume":"16","author":"NS Bajaj","year":"2019","journal-title":"PLoS Med"},{"issue":"4","key":"pone.0340889.ref024","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MCP.0000000000000964","article-title":"Home monitoring of coronavirus disease 2019 patients in different phases of disease","volume":"29","author":"K Majoor","year":"2023","journal-title":"Curr Opin Pulm Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:32:40Z","timestamp":1769797960000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340889"}},"subtitle":[],"editor":[{"given":"Ey\u00fcp Serhat","family":"\u00c7al\u0131k","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0340889","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}